Peri/ZentroOlimel

The Olimel portfolio gives you the broadest selection of three-chamber bags with an olive oil-based lipid to meet the unique nutrition needs of each patient.

See indications Contact Us
Hero image Peri ZentroOlime

Not all critically ill patients are the same, and neither are their nutritional requirements. The Peri/ZentroOlimel portfolio offers a range of central and peripheral formulations to match the individual protein and energy needs of your patients.1-3  ZentroOlimel 7,6% combines a high protein formulation with low glucose content, resulting in the lowest energy to protein ratio currently available in a standardized, three-chamber bag (3CB).2,3,18-23  Peri/ZentroOlimel contains olive oil, which is rich in long-chain Omega-9 monounsaturated fatty acids (MUFAs), with fewer polyunsaturated fatty acids (PUFAs) than soybean and fish oil.26 An olive oil-based lipid emulsion may preserve immune function and has been associated with fewer infections than soybean oil.4,10-12

Patient and doctor in hospital

Meeting protein targets is key to hospitalized patients’ recovery

During recovery, hospitalized patients face two serious challenges. Firstly, they may be immunocomprimised which can lead to severe complications.5 Secondly, catabolic stress from acute infection, trauma or severe tissue injury depletes protein stores in the skeletal muscle which can lead to poor wound healing, muscle weakness, prolonged ventilator time, and extended hospital stay.6-8 Proper protein intake with parenteral nutrition (PN) not only ensures sufficient caloric intake but also an essential nutrient balance. Still, most critically ill patients receive only half the recommended protein intake during their first weeks in the intensive care unit (ICU).9   

Olimel - meeting the unique nutritional needs of each patient

Preserve immune function icon

Preserve immune function

Peri/ZentroOlimel contains an olive oil-based lipid emulsion, which is associated with fewer infections and may preserve immune function.4,10-12

Reach protein targets  with less fluid icon

Reach protein targets with less fluid

ZentroOlimel 7,6% combines a high protein formulation with low glucose content.

Personalize without compromise icon

Personalize without compromise

Broad selection of 3CBs to meet the unique nutrition needs of each patient.1-3

Reduce risk of hyperglycemia icon

Reduce risk of hyperglycemia

Hyperglycemia is associated with an increased risk of infections.15-19 With only 73 g/L, ZentroOlimel 7,6% has one of the lowest glucose levels available in a 3CB.2,3,18-23

Learn about the importance of protein in PN

Dr. Paul Wischmeyer explains the power of protein. Olimel was not administered in these studies.

The power of protein

When compared to standard intake, higher protein as prescribed by guidelines was associated with significant clinical improvements in ICU patients.24 A higher and earlier intake of protein has proven to be beneficial in wound healing, hormonal regulation, and cell signaling and was significantly associated with lower mortality as illustrated by a one percent reduction in mortality for every gram of daily protein ingested.7,25

Association of protein intake with 60-day mortality25

Graph adapted from Zusman O, et al. Crit Care 2016;20;367-374(39) showing that the results from the study suggests a  1% reduction in mortality for every 1 gram of daily protein ingested.
Graph adapted from Zusman O, et al. Crit Care 2016;20;367-374(39) showing that the results from the study suggests a 1% reduction in mortality for every 1 gram of daily protein ingested.

Browse the Olimel portfolio

Zentro Olimel 7,6% composition

ZentroOlimel 7,6%

For patients with high catabolic stress 

ZentroOlimel 7,6% is Baxter’s latest generation of industry-leading PN 3CBs and combines a high protein formulation with low glucose content.2,3  ZentroOlimel 7,6% also contains an olive oil-based lipid emulsion which is supported by more than 20 years of proven clinical evidence.  

ZentroOlimel 7,6% is formulated for PN in patients with the highest protein demand, or patients who are at risk of overfeeding or fluid overload. ZentroOlimel 7,6% without electrolytes can be administered to provide protein, fatty acids and calories to non-acutely ill malnourished patients receiving intradialytic PN (IDPN).

See full prescribing information for ZentroOlimel 7,6% SmPC

See full prescribing information for ZentroOLIMEL 7,6% mit Elektrolyten SmPC

Zentro Olimel 5,7% composition

ZentroOlimel 5,7%

For patients with moderate catabolic stress 

ZntroOlimel 5,7% is formulated for PN in moderate stress patients with high protein and moderate energy demands. ZentroOlimel 5,7% without electrolytes can be administered to provide protein, fatty acids and calories to non-acutely ill malnourished patients receiving IDPN. 

See full prescribing information for ZentroOlimel 5,7% SmPC 

See full prescribing information for ZentroOLIMEL 5,7% mit Elektrolyten SmPC

Zentro Olimel 4,4% composition

ZentroOlimel 4,4%

For patients with moderate catabolic stress 

ZentroOlimel 4,4% is formulated for PN in moderate stress patients in stable conditions with moderate protein and higher energy demands. 

See full prescribing information
Zentro Olimel 3,3% composition

ZentroOlimel 3,3%

For patients with low catabolic stress

ZentroOlimel 3,3% is formulated for PN in low stress patients in stable conditions with moderate protein and higher energy demands. 

See full prescribing information
PeriOlimel 2,5% composition

PeriOlimel 2,5%

For patients with low catabolic stress 

PeriOlimel 2,5% is formulated for PN in stable patients that need a conveniently delivered, short-term nutrition solution.  PeriOlimel 2,5% is specifically formulated for peripheral delivery. 

See full prescribing information

How to activate an Olimel bag

How to activate an Olimel bag visual

1. Peel the overpouch

Peel the front of overpouch using the notches. Discard the overpouch. Confirm the integrity of the bag and nonpermanent seals. Use only if the bag is not damaged and the nonpermanent seals are intact.

2. Roll the bag

Place the bag flat and manually roll the bag onto itself, starting at the top of the bag (hanger end). Continue to roll the bag until the seals are opened along approximately half of their length.

3. Mix the content 

Mix by inverting the bag at least 3 times. After reconstitution, the mixture is a homogeneous emulsion with a milky appearance.

4. Add micronutrients and other additions (if needed)

The capacity of the bag is sufficient to enable additions such as vitamins, electrolytes, and trace elements. Also, vitamins may be added into the glucose compartment before the mixture is reconstituted. Any further additions may be made into the reconstituted mixture. After any additions are made, mix the contents of the bag and the additives.

To perform an addition:
- Aseptic conditions must be observed.
- Prepare the injection site of the bag.
- Puncture the injection site and inject the additives using an injection needle or a reconstitution device.
- Mix content of the bag and the additives.

Compatibility may vary between products from different sources and health care professionals are advised to carry out appropriate checks when mixing Olimel with other parenteral solutions.

5. Administer PeriOlimel/Olimel
Aseptic conditions must be observed. Remove the plastic protector. Twist off the protector from the administration outlet and firmly insert the spike of the infusion set into the administration outlet. The recommended duration of infusion is between 12 and 24 hours.

Learn more about Clinical Nutrition

Doctors talking

Visit the Clinical Nutrition Resource Library to access additional resources

Related Products

Important safety information

Peri/ZentroOLIMEL 

Bezeichnung: PeriOLIMEL 2,5 % mit Elektrolyten – Emulsion zur Infusion // ZentroOLIMEL 3,3 % / 4,4 % / 5,7 % / 7,6% mit Elektrolyten – Emulsion zur Infusion // 5,7 % / 7,6% - Emulsion zur Infusion. 

Pharmakotherapeutische Gruppe: Lösungen zur parenteralen Ernährung / Kombinationen. ATC-Code: B05 BA10. 

Qualitative und Quantitative Zusammensetzung: PeriOLIMEL, ZentroOLIMEL 3,3 %, 4,4%, 5,7%, 7,6% mit Elektrolyten, ZentroOLIMEL 5,7 %, 7,6% wird in einem Dreikammer-Beutel geliefert. Jeder Beutel enthält eine Glucoselösung (mit Calcium), eine Lipidemulsion und eine Aminosäurenlösung (mit anderen Elektrolyten). 

Wirkstoffe: 1.500 ml gebrauchsfertige Emulsion enthalten: Raffiniertes Olivenöl + raffiniertes Sojaöl(a) 45//60/60/60/52,5//60/52,5 g, Alanin 5,50//7,14/9,61/12,36/16,48//12,36/16,48 g, Arginin 3,72//4,84/6,51/8,37/11,16//8,37/11,16 g, Asparaginsäure 1,10//1,43/1,92/2,47/3,3//2,47/3,3 g, Glutaminsäure 1,90//2,47/3,32/4,27/5,69//4,27 /5,69g, Glycin 2,63//3,42/4,60/5,92/7,9//5,92 /7,9g, Histidin 2,26//2,95/3,97/5,09/6,79//5,09/6,79 g, Isoleucin 1,90//2,47/3,32/4,27/5,69//4,27/5,69 g, Leucin 2,63//3,42/4,60/5,92/7,9//5,92/6,79/7,9 g, Lysin (entspricht Lysinacetat) 2,99 // 3,88 / 5,23 / 6,72/8,96 // 6,72 /8,96 g (4,21 // 5,48 / 7,31 / 9,48/12,64 // 9,48/12,64 g), Methionin 1,90//2,47/3,32/4,27/5,69//4,27 /5,69g, Phenylalanin 2,63//3,42/4,60/5,92/7,96//5,92/7,96 g, Prolin 2,26//2,95/3,97/5,09/6,79//5,09/6,79 g, Serin 1,50//1,95/2,62/3,37/4,50//3,37/4,50 g, Threonin 1,90//2,47/3,32/4,27/5,69//4,27/5,69 g, Tryptophan 0,64//0,82/1,10/1,42/1,90//1,42/1,90 g, Tyrosin 0,10//0,13/0,17/0,22/0,30//0,22/0,30 g, Valin 2,43//3,16/4,25/5,47/7,29//5,47/7,29 g, Natriumacetat-Trihydrat 1,73//2,24/2,24/2,24/2,24//- g/-g,
Natriumglycerophosphat, hydratisiert 2,87//5,51/5,51/5,51/5,51//-g/-g, Kaliumchlorid 1,79//3,35/3,35/3,35/3,35//- g/-g, Magnesiumchlorid-Hexahydrat 0,67//1,22/1,22/1,22/1,22//- g/-g, Calciumchlorid-Dihydrat 0,44//0,77/0,77/0,77/0,77//- g/-g, Glucose (entspricht Glucose-Monohydrat) 112,50 // 172,50 / 210,00 / 165,00/110,00 // 165,00/110,00 g (123,75 // 189,75 / 231,00 / 181,50/121,00 // 181,50/121,00 g). (a) Mischung aus raffiniertem Olivenöl (ca. 80 %) und raffiniertem Sojaöl (ca. 20 %), entsprechend einem Anteil von 20 % essenziellen Fettsäuren gemessen am Gesamtfettsäurengehalt. 

Nährstoffzufuhr der gebrauchsfertigen Emulsion: 1.500ml enthalten: Lipide: 45//60/60/60/52,5//60/52,5g; Aminosäuren: 38//49,4/66,4/85,4/113,9//85,4/113,9g; Stickstoff: 6,0//7,8/10,5/13,5/18,0//13,5/18,0g;Glucose: 112,5//172,5/210,0/165,0/110//165,0/110g; Energie: Gesamtkalorien ca. 1050//1490/1750/1600/1420//1600/1420kcal; Nichteiweiß-Kalorien ca. 900//1290/1440/1260/960//1260/960 kcal; Glucosekalorien: 450//690/840/660/430//660/430kcal; Fettkalorien ca.(a) 450//600/600/600/520//600/520kcal; Verhältnis Nichteiweiß Kalorien/Stickstoff: 150//165/127/93/53//93/53kcal/g; Verhältnis Glucose-/Fettkalorien: 50/50 // 53/47 / 58/42 / 52/48 /45/55 // 52/48/45/55; Fett-/Gesamtkalorien: 43//47/35/37/37//37/37%; Elektrolyte: Natrium: 31,5//52,5/52,5/52,5/52,5//-/- mmol; Kalium: 24//45/45/45/45//-/- mmol; Magnesium: 3,3//6/6/6/6//-/- mmol; Calcium: 3//5,3/5,3/5,3/5,3//-/- mmol;Phosphat(b): 12,7//22,5/22,5/22,5/21,9//4,5/3,9 mmol; Acetat: 41//55/67/80/105//60/80 mmol; Chlorid: 37//68/68/68/68//- mmol; pH-Wert ca. 6,4; Osmolarität ca. 760//1120/1360/1310/1270//1170/1130 mOsm/l. (a)Einschließlich der Kalorien aus gereinigten Phospholipiden aus Eiern (b)Einschließlich des Phosphats aus der Lipidemulsion. 

Liste der sonstigen Bestandteile: Kammer mit Lipidemulsion: Gereinigte Phospholipide aus Eiern, Glycerol, Natriumoleat, Natriumhydroxid (zur pH-Einstellung), Wasser für Injektionszwecke. Kammer mit Aminosäurenlösung mit Elektrolyten: Essigsäure (zur pH-Einstellung), Wasser für Injektionszwecke. Kammer mit Glucoselösung mit Calcium: Salzsäure (zur pH-Einstellung), Wasser für Injektionszwecke. 

Anwendungsgebiete: PeriOLIMEL 2,5%, ZentroOLIMEL 3,3 %, 4,4%, 5,7%, 7,6% mit Elektrolyten, ZentroOLIMEL 5,7%, 7,6% wird für die parenterale Ernährung bei Erwachsenen und Kindern über 2 Jahre angewendet, wenn eine orale oder enterale Ernährung nicht möglich, unzureichend oder kontraindiziert ist. 

Gegenanzeigen: Die Anwendung von PeriOLIMEL, ZentroOLIMEL mit Elektrolyten ist kontraindiziert bei: Frühgeborenen, Neugeborenen und Kindern unter 2 Jahren / Überempfindlichkeit gegen Ei, Soja, Erdnussproteine oder Mais/Maisprodukte (siehe Abschnitt 4.4) oder einen der Wirkstoffe oder einen der in Abschnitt 6.1 genannten sonstigen Bestandteile / Angeborenen Störungen des Aminosäurenstoffwechsels / Schwerer Hyperlipidämie oder schweren Störungen des Lipidmetabolismus, gekennzeichnet durch Hypertriglyceridämie / Schwerer Hyperglykämie / Pathologisch erhöhten Natrium-, Kalium-, Magnesium-, Calcium- und/oder Phosphatkonzentrationen im Plasma. (gilt nur für PeriOLIMEL, ZentroOLIMEL 3,3 %, 4,4%, 5,7 %, 7,6% mit Elektrolyten) Inhaber der Zulassung: Baxter Healthcare GmbH, A-1020 Wien Stand der Information: März 2020 Verschreibungspflicht/Apothekenpflicht: Rezept- und apothekenpflichtig.  

Weitere Angaben zu “Besondere Warnhinweise und Vorsichtsmaßnahmen für die Anwendung“, „Wechselwirkungen mit anderen Arzneimitteln und sonstige Wechselwirkungen“, „Fertilität, Schwangerschaft und Stillzeit“ und „Nebenwirkungen“ sind der veröffentlichten Fachinformation zu entnehmen.